BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23847378)

  • 21. The SWI/SNF chromatin remodelling complex: Its role in maintaining genome stability and preventing tumourigenesis.
    Brownlee PM; Meisenberg C; Downs JA
    DNA Repair (Amst); 2015 Aug; 32():127-133. PubMed ID: 25981841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
    Menendez JA; Vellon L; Lupu R
    Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
    Vachtenheim J; Ondrusová L; Borovanský J
    Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the SWI/SNF chromatin-remodeling complex during early heart development and BAF250a repression cardiac gene transcription during P19 cell differentiation.
    Singh AP; Archer TK
    Nucleic Acids Res; 2014 Mar; 42(5):2958-75. PubMed ID: 24335282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability.
    Husain A; Begum NA; Taniguchi T; Taniguchi H; Kobayashi M; Honjo T
    Nat Commun; 2016 Feb; 7():10549. PubMed ID: 26842758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRG1-mediated chromatin remodeling regulates differentiation and gene expression of T helper cells.
    Wurster AL; Pazin MJ
    Mol Cell Biol; 2008 Dec; 28(24):7274-85. PubMed ID: 18852284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells.
    Hagiwara M; Yasumizu Y; Yamashita N; Rajabi H; Fushimi A; Long MD; Li W; Bhattacharya A; Ahmad R; Oya M; Liu S; Kufe D
    Cancer Res; 2021 Feb; 81(4):1111-1122. PubMed ID: 33323379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sister chromatid decatenation: bridging the gaps in our knowledge.
    Broderick R; Niedzwiedz W
    Cell Cycle; 2015; 14(19):3040-4. PubMed ID: 26266709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CK2-Dependent Phosphorylation of the Brg1 Chromatin Remodeling Enzyme Occurs during Mitosis.
    Padilla-Benavides T; Haokip DT; Yoon Y; Reyes-Gutierrez P; Rivera-Pérez JA; Imbalzano AN
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1-mediated ubiquitination inhibits topoisomerase II alpha activity in response to oxidative stress.
    Shinagawa H; Miki Y; Yoshida K
    Antioxid Redox Signal; 2008 May; 10(5):939-49. PubMed ID: 18162055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTEN stabilizes TOP2A and regulates the DNA decatenation.
    Kang X; Song C; Du X; Zhang C; Liu Y; Liang L; He J; Lamb K; Shen WH; Yin Y
    Sci Rep; 2015 Dec; 5():17873. PubMed ID: 26657567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoid Receptor Transcriptional Activation via the BRG1-Dependent Recruitment of TOP2β and Ku70/86.
    Trotter KW; King HA; Archer TK
    Mol Cell Biol; 2015 Aug; 35(16):2799-817. PubMed ID: 26055322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation of the chromatin remodeling factor DPF3a induces cardiac hypertrophy through releasing HEY repressors from DNA.
    Cui H; Schlesinger J; Schoenhals S; Tönjes M; Dunkel I; Meierhofer D; Cano E; Schulz K; Berger MF; Haack T; Abdelilah-Seyfried S; Bulyk ML; Sauer S; Sperling SR
    Nucleic Acids Res; 2016 Apr; 44(6):2538-53. PubMed ID: 26582913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint.
    Vries RG; Bezrookove V; Zuijderduijn LM; Kia SK; Houweling A; Oruetxebarria I; Raap AK; Verrijzer CP
    Genes Dev; 2005 Mar; 19(6):665-70. PubMed ID: 15769941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromatin-remodelling factor BRG1 selectively activates a subset of interferon-alpha-inducible genes.
    Huang M; Qian F; Hu Y; Ang C; Li Z; Wen Z
    Nat Cell Biol; 2002 Oct; 4(10):774-81. PubMed ID: 12244326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming.
    Singhal N; Graumann J; Wu G; Araúzo-Bravo MJ; Han DW; Greber B; Gentile L; Mann M; Schöler HR
    Cell; 2010 Jun; 141(6):943-55. PubMed ID: 20550931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions.
    Williams AO; Isaacs RJ; Stowell KM
    BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.
    Bower JJ; Karaca GF; Zhou Y; Simpson DA; Cordeiro-Stone M; Kaufmann WK
    Oncogene; 2010 Aug; 29(34):4787-99. PubMed ID: 20562910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes.
    Zhang Y; Cheng MB; Zhang YJ; Zhong X; Dai H; Yan L; Wu NH; Zhang Y; Shen YF
    Cell Res; 2010 Dec; 20(12):1345-60. PubMed ID: 21079652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
    Nikolényi A; Sükösd F; Kaizer L; Csörgo E; Vörös A; Uhercsák G; Ormándi K; Lázár G; Thurzó L; Brodowicz T; Kahán Z
    Oncology; 2011; 80(3-4):269-77. PubMed ID: 21734419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.